Cooperation Between Aflatoxin-Induced p53 Aberrations and Hepatitis B Virus in Hepatocellular Carcinoma
Journal of Xenobiotics · 20.06.2025 · 15 (4) · 96
DOI: 10.3390/jox15040096 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Xenobiotics, online erschienen am 20.06.2025. Verfasst von Carolina Moreno-León und 1 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Oncovirología, Departamento de Ciencias Biomédicas, Facultad de Medicina, Universidad de Tarapacá, Arica 1000000, Chile. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondecyt, Fondecyt Regular.
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) imposes a significant burden on global public health. Exposure to aflatoxins, potent mycotoxins produced by Aspergillus fungi contaminating staple foods, and chronic hepatitis B virus (HBV) infection are major etiological factors, especially where they co-exist. This review examines the critical role of the p53 tumor suppressor pathway as a primary target and convergence point for the carcinogenic actions of aflatoxins and HBV. Aflatoxin B1 (AFB1), a Group 1 carcinogen, exerts significant genotoxicity, characteristically inducing a specific hotspot mutation (R249S) in the TP53 gene via DNA adduct formation, thereby compromising p53’s critical tumor suppressor functions. This R249S mutation is considered a molecular fingerprint of aflatoxin exposure. Concurrently, the HBV X protein (HBx) functionally inactivates wild-type p53 through direct binding and by promoting its degradation. The synergistic disruption of the p53 pathway, driven by AFB1-induced mutation and amplified by HBV-mediated functional inhibition, significantly enhances the risk of HCC development. This review addresses how aflatoxin exposure alters key aspects of p53 and how this damage interacts with HBV-mediated p53 suppression, providing crucial insights into hepatocarcinogenesis. The knowledge synthesized here underscores the importance of mitigating aflatoxin exposure alongside HBV control for effective HCC prevention and treatment strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratorio de Oncovirología, Departamento de Ciencias Biomédicas, Facultad de Medicina, Universidad de Tarapacá, Arica 1000000, Chile.
ORCID-Profile: Francisco Aguayo
Förderung
- Fondecyt
- Fondecyt Regular
Zitieren
APA
Moreno-León, C., & Aguayo, F. (2025). Cooperation Between Aflatoxin-Induced p53 Aberrations and Hepatitis B Virus in Hepatocellular Carcinoma. Journal of Xenobiotics, 15(4), 96. https://doi.org/10.3390/jox15040096
Vancouver
Moreno-León C, Aguayo F. Cooperation Between Aflatoxin-Induced p53 Aberrations and Hepatitis B Virus in Hepatocellular Carcinoma. Journal of Xenobiotics. 2025;15(4):96. doi:10.3390/jox15040096
BibTeX
@article{MorenoLen2025,
author = {Moreno-León, Carolina and Aguayo, Francisco},
title = {Cooperation Between Aflatoxin-Induced p53 Aberrations and Hepatitis B Virus in Hepatocellular Carcinoma},
journal = {Journal of Xenobiotics},
year = {2025},
volume = {15},
number = {4},
pages = {96},
doi = {10.3390/jox15040096}
}
EUVIMED